- Home
- BMY vs EQNR Comparison
BMY vs EQNR Comparison
Compare BMY & EQNR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BMY | EQNR |
|---|---|---|
| Founded | 1887 | 1972 |
| Country | United States | Norway |
| Employees | 32500 | 24140 |
| Industry | Biotechnology: Pharmaceutical Preparations | Integrated oil Companies |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 113.5B | 93.7B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | BMY | EQNR |
|---|---|---|
| Price | $55.94 | $33.82 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 15 | 4 |
| Target Price | ★ $61.73 | $37.00 |
| AVG Volume (30 Days) | ★ 10.0M | 3.6M |
| Earning Date | 04-30-2026 | 05-06-2026 |
| Dividend Yield | ★ 4.38% | 3.08% |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | $13.35 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $17.26 | ★ $14.56 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $42.52 | $22.26 |
| 52 Week High | $62.89 | $43.46 |
Technical Indicators
Market Signals| Indicator | BMY | EQNR |
|---|---|---|
| Relative Strength Index (RSI) | 44.55 | 33.87 |
| Support Level | $53.98 | $22.88 |
| Resistance Level | $57.43 | $41.57 |
| Average True Range (ATR) | 1.32 | 0.85 |
| MACD | 0.03 | -0.35 |
| Stochastic Oscillator | 39.97 | 2.50 |
Price Performance
Historical ComparisonAbout BMY Bristol-Myers Squibb Company
Bristol Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.
About EQNR Equinor ASA
Equinor is a Norway-based integrated oil and gas company. It has been publicly listed since 2001, but the government retains a 67% stake. Operating primarily on the Norwegian Continental Shelf, the firm produced 2.1 million barrels of oil equivalent per day in 2025 (50% liquids) and ended 2025 with 5.2 billion barrels of proven reserves (45% liquids). Operations also include oil refineries and natural gas processing, marketing, and trading. The renewables portfolio includes offshore and onshore wind and solar, with total power generation of 5.65 TWh in 2025.